Aaron Berutti - 09 Aug 2025 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Aug 2025, 21:30:06 UTC
Prior SEC filing
11 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lisa Taylor as Attorney-in-fact for Aaron Berutti
Filing notes and source

Key filing fact

Aaron Berutti filed Form 4 for TREACE MEDICAL CONCEPTS, INC. (TMCI) on 12 Aug 2025.

Key facts

  • This page summarizes Aaron Berutti's Form 4 filing for TREACE MEDICAL CONCEPTS, INC. (TMCI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Aug 2025, 21:30.

Change

  • Previous filing in this sequence was filed on 11 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001871334 Primary reporting owner

Berutti Aaron

Relationship
SVP, Sales
Address
C/O TREACE MEDICAL CONCEPTS, INC., 100 PALMETTO PARK PLACE, PONTE VEDRA
Signature
/s/ Lisa Taylor as Attorney-in-fact for Aaron Berutti
Signature date
12 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMCI transaction

Common Stock

Tax liability

Transaction value
$0
Shares
-4,907
Change %
-2.3%
Price
$0.000000
Shares after
205,092
Date
09 Aug 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 181,955 restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .